Biotech IPO proceeds in the first quarters of 2018 to 2024, with $1.3 billion raised in 2024 and peaking at $4.6 billion in 2021.
Total biotech IPO proceeds during the first quarter of each year, in millions of dollars.
Chart: Gwendolyn WuSource: BioPharma DiveCreated with Datawrapper